| Product Code: ETC9470195 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sri Lanka Hereditary Angioedema Therapeutic Market Overview |
3.1 Sri Lanka Country Macro Economic Indicators |
3.2 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Sri Lanka Hereditary Angioedema Therapeutic Market - Industry Life Cycle |
3.4 Sri Lanka Hereditary Angioedema Therapeutic Market - Porter's Five Forces |
3.5 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Sri Lanka Hereditary Angioedema Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hereditary angioedema (HAE) in Sri Lanka |
4.2.2 Rising prevalence of HAE in the region |
4.2.3 Technological advancements in HAE treatment options |
4.2.4 Growing healthcare infrastructure and access to treatment |
4.2.5 Favorable government initiatives and policies supporting HAE management |
4.3 Market Restraints |
4.3.1 Limited availability and affordability of HAE therapies |
4.3.2 Lack of specialized healthcare professionals for HAE diagnosis and treatment |
4.3.3 Challenges in accurate diagnosis of HAE due to its rarity and similarity to other conditions |
4.3.4 Regulatory hurdles and delays in approval of HAE treatments |
4.3.5 Cultural or social stigma related to genetic disorders impacting patient seeking treatment |
5 Sri Lanka Hereditary Angioedema Therapeutic Market Trends |
6 Sri Lanka Hereditary Angioedema Therapeutic Market, By Types |
6.1 Sri Lanka Hereditary Angioedema Therapeutic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type I Hereditary Angioedema (HAE), 2021- 2031F |
6.1.4 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type II Hereditary Angioedema (HAE), 2021- 2031F |
6.1.5 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By Type III Hereditary Angioedema (HAE), 2021- 2031F |
6.2 Sri Lanka Hereditary Angioedema Therapeutic Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By C-1 Esterase Inhibitors, 2021- 2031F |
6.2.3 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By Bradykynin B2 Receptor Antagonist, 2021- 2031F |
6.2.4 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By Kallikrein Inhibitors, 2021- 2031F |
6.2.5 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sri Lanka Hereditary Angioedema Therapeutic Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By Prophylaxis, 2021- 2031F |
6.3.3 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By Treatment, 2021- 2031F |
6.4 Sri Lanka Hereditary Angioedema Therapeutic Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Sri Lanka Hereditary Angioedema Therapeutic Market Revenues & Volume, By Injectable, 2021- 2031F |
7 Sri Lanka Hereditary Angioedema Therapeutic Market Import-Export Trade Statistics |
7.1 Sri Lanka Hereditary Angioedema Therapeutic Market Export to Major Countries |
7.2 Sri Lanka Hereditary Angioedema Therapeutic Market Imports from Major Countries |
8 Sri Lanka Hereditary Angioedema Therapeutic Market Key Performance Indicators |
8.1 Average time to diagnose HAE in Sri Lanka |
8.2 Number of HAE treatment centers or specialized clinics in the country |
8.3 Patient adherence rates to prescribed HAE therapies |
8.4 Rate of hospitalizations due to HAE attacks |
8.5 Number of educational programs or events on HAE organized in Sri Lanka |
9 Sri Lanka Hereditary Angioedema Therapeutic Market - Opportunity Assessment |
9.1 Sri Lanka Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sri Lanka Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Sri Lanka Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Sri Lanka Hereditary Angioedema Therapeutic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Sri Lanka Hereditary Angioedema Therapeutic Market - Competitive Landscape |
10.1 Sri Lanka Hereditary Angioedema Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Sri Lanka Hereditary Angioedema Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here